Detalhe da pesquisa
1.
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines.
J Virol
; 98(1): e0147823, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085509
2.
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
PLoS Pathog
; 19(11): e1011772, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943890
3.
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response.
Clin Immunol
; 259: 109877, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141746
4.
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
J Virol
; 96(15): e0055822, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867572
5.
Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey (Vervet) model.
Sci Rep
; 14(1): 13311, 2024 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38858452
6.
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
PLOS Glob Public Health
; 4(4): e0002703, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603677
7.
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
Front Immunol
; 14: 1231276, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600825
8.
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.
NPJ Vaccines
; 8(1): 119, 2023 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573434
9.
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant.
Cell Rep Med
; 4(1): 100910, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603577
10.
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
medRxiv
; 2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36993404
11.
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial.
Lancet Infect Dis
; 23(3): 295-306, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273491
12.
Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor.
Cell Rep
; 42(2): 112044, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708513
13.
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
medRxiv
; 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38045321
14.
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms.
Sci Rep
; 12(1): 16473, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36182959
15.
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity.
Cell Rep Med
; 3(2): 100510, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233544
16.
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern.
Cell Rep Med
; 3(3): 100535, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474744
17.
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals.
Cell Host Microbe
; 30(6): 880-886.e4, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436444
18.
Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage.
Nat Commun
; 13(1): 1976, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35396511
19.
HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function.
Front Immunol
; 12: 733958, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34566999
20.
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner.
Cell Host Microbe
; 29(11): 1611-1619.e5, 2021 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688376